Meeting details
Date:
Speaker:
Venue: Start time:
Thursday 1st June 2023
Dr Kingsley Nirmalaraj
The Charthouse
72 Keith Allen Drive
Tauranga
6.30pm
1 Obesity & weight management in New Zealand
• Clinical challenges, treatment goals & treatment options
2 Challenges of weight maintenance & Saxenda® clinical development program key findings
• Appetite regulation, the mechanism behind weight regain and the role of Saxenda®
3 Clinical practicalities and case studies with Saxenda®
• Getting your patients started on Saxenda®
4 Q&A
5 How to raise the topic of weight with your patients
We would like to invite you to the Novo Nordisk Saxenda ® education meeting, a short interactive program designed to introduce and enhance your management of obesity This program includes an in-depth discussion around the role of Saxenda ® in weight management To
https://www.eventleaf.com/e/Saxenda_NZ09
Lee on LECU@novonordisk or 027 369 4963
The importance of managing obesity in a multidisciplinary approach & understanding the role of Saxenda® in weight management.
Dr Kingsley Nirmalaraj MBBS,FRACP, FACE
Dr Kingsley Nirmalaraj MBBS, FRACP, FACE is a Consultant Endocinologist and Physician with expertise in Endocrinology, Metabolism and Diabetes as well as endocrine disorders complicating pregnancy. He has been working as a consultant at Tauranga Hospital and Bay Endocrinology, Suite 9, Promed House Tauranga.
Meeting details
Date:
Speaker: Venue:
RSVP:
Thursday 1st June 2023
Dr Kingsley Nirmalaraj
The Charthouse
Monday 29th May 2023
Agenda:
6.30pm - Arrival and Registration
7.00pm - Entree served at table
7.15pm - Presentation by Dr Kingsley Nirmalaraj
8.15pm - Mains Served
8.30pm - Q&A and Dessert
9.00pm - Close
Saxenda® is a prescription medicine that is not funded. For weight management in adult patients with BMI of ≥30 kg/m2 (obese) or ≥ 27 kg/m2 to <30 kg/m2 (overweight) in the presence of at least one weight related comorbidity Before prescribing Saxenda ® , please review the datasheet for information on dosage, contraindications, precautions, interactions and adverse effects One pre-filled pen contains 18 mg of liraglutide in 3 ml The Data Sheet is available at novonordisk.co.nz
In accordance with the Code of Practice for the prescription medicines industry in New Zealand, any costs (for example travel or meals) incurred by a partner/ spouse, guest or family member travelling with a healthcare professional must not be paid for or subsidised by the company Novo Nordisk holds your information in accordance with the Privacy Act 1993, including for marketing unless you tell us not to. You may ask to access your information For a copy of our privacy policy call Novo Nordisk Customer Care Centre on 0800 733 737 or visit www.novonordisk co nz
References 1. Caterson ID, Alfadda AA, Auerbach P, et al Gaps to bridge: misalignment between perception, reality and actions in obesity Diabetes Obes Metab. 2019;1–11
Saxenda® Data Sheet